The Latest Breaking News from Pfizer

The FDA has granted emergency use authorization (EUA) to Pfizer Inc (NYSE:PFE) and BioNTech SE's (NASDAQ:BNTX) COVID-19 Vaccine as a three 3-µg dose series for children six months through 4 years of age.  Based on safety, tolerability, and immunogenicity data, the 3-µg dose was carefully selected as the preferred dose for children under five. The EUA…

FDA’s action follows its advisory panel’s unanimous recommendation for the shots from Moderna and Pfizer

One and a half years after the adult COVID-19 vaccine, a kids' shot is here. This is why it took so much longer

Gov. Ron DeSantis on Thursday defended the state’s decision not to preorder COVID-19 pediatric vaccines for children under 5, saying that parents who want the shots can access them without the state’s help.

After US regulators took a major step towards approving COVID-19 vaccines for kids under five, here's what you need to know about the possibility of something similar happening in Australia.

Here's a roundup of top developments in the biotech space over the last 24 hours:

In this edition of Inverse Daily, read about the tarantula nebula, making decisions using science, and more.

Akero Therapeutics Inc (NASDAQ:AKRO) announced a $25 million equity investment by Pfizer Inc (NYSE:PFE) at $9.90 per share.  The company also announced a term loan facility providing Akero with access to up to $100 million from Hercules Capital Inc (NYSE:HTGC), of which $10 million will be drawn at transaction close.  Together with existing cash, proceeds will support…

Looking for a mutual fund that's a safe haven from a scary stock market? Check out tiny $24.7 million Archer Dividend Growth Fund.